Pecos Medicaid providers billed $56,677 for pathology and lab work in 2024, a 7% rise over prior year

Pecos Medicaid providers billed $56,677 for services within the Pathology and Laboratory Procedures category in 2024, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database. This amount reflects a 6.9% rise from 2023, when claims for these services totaled $53,008.

Medicaid is a state-administered public insurance program funded jointly by federal and state governments. The program assists low-income individuals, families, children, seniors, and people with disabilities, making it one of the main segments of U.S. health care.

With Medicaid funding sourced from taxpayers, shifting local billing trends reflect how community public health dollars are allocated.

The “Pathology and Laboratory Procedures” group consists of standardized Medicaid-billed care types, organized using HCPCS and CPT code prefixes and numeric bands for this analysis. Each code falls under a single service classification, which allows related care to be measured together for precise tracking and ranking over time.

Pathology and Laboratory Procedures represented the third-largest Medicaid payment category in Pecos in 2024, as spending in this and other service groups increased.

Across Texas that year, Pathology and Laboratory Procedures ranked sixth among service categories in terms of total Medicaid disbursements.

Between 2019 and 2024, Medicaid payments earmarked for Pathology and Laboratory Procedures in Pecos climbed $49,348, or 673.3%. Several periods, most notably 2020 and 2021, saw significant yearly increases in spending.

Although Medicaid reimbursements for Pathology and Laboratory Procedures were distributed citywide, payments concentrated in a handful of ZIP codes. In 2024, ZIP code 79772 accounted for the full $56,677 in Medicaid funding under this category, representing 100% of related payments in Pecos during the year.

A limited selection of billing codes constituted most Medicaid spending within the Pathology and Laboratory Procedures group.

In comparison, the 6.9% increase in Medicaid payments for Pathology and Laboratory Procedures in Pecos from 2023 to 2024 lagged behind the overall 34.4% rise across all Medicaid claim types within the city during the period.

The Centers for Medicare & Medicaid Services reports that combined state and federal Medicaid outlays topped $871.7 billion in fiscal 2023, comprising around 18% of total U.S. health expenditures, up markedly from $613.5 billion in 2019, before the COVID-19 pandemic.

This reflects about 40% growth in a few years, mainly due to expanded enrollment and increased utilization throughout the pandemic and afterwards.

Recent budget legislation under the Trump administration included major proposals to curtail federal Medicaid funds and overhaul the program. A notable example is the “One Big Beautiful Bill Act,” signed in 2025, which is projected to reduce federal Medicaid spending by more than $1 trillion over the next 10 years and introduces stricter requirements such as work mandates and heightened cost-sharing. These changes could diminish support and coverage for some Medicaid participants by shifting more responsibilities to state governments, potentially slowing the growth of federal program support, even while the program continues to serve millions nationwide.

Note: HCPCS codes are included for additional context. Category totals and rankings use standardized service groupings, not individual billing codes.

This article draws information from the U.S. Department of Health and Human Services Medicaid Provider Spending database, available here.